Literature DB >> 27426018

Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight.

Ewa Rudnicka1, Stanislaw Radowicki2, Katarzyna Suchta1.   

Abstract

INTRODUCTION: Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder and cause of androgen excess in women. Prostate specific antigen (PSA) could be a new marker of hyperandrogenism in PCOS.
OBJECTIVE: The aim of the study was to assess the concentration PSA (total PSA - TPSA and free PSA - fPSA) in 165 patients with PCOS and 40 healthy female controls, the relationship between PSA (TPSA and fPSA) and hormonal parameters and to determine the performance of PSA in diagnosis of PCOS.
RESULTS: Total PSA was higher in PCOS group versus controls. The fPSA was below the lower detection levels among all patients. The median value of FAI was 4.31 in PCOS patients versus 1.79 in controls, p < 0.001. There was a correlation of TPSA and tT (r= 0.173, p = 0.027) and TPSA and FAI (r = 0.2603, p = 0.001). AUC for FAI was 82.1%, threshold 2.56 nmol/l, for tT AUC 80.5%, threshold 0.54 ng/ml, for TPSA AUC 66.3%, threshold 0.005 ng/ml. The ROC analysis for A AUC 62.7%, threshold 3.95 ng/ml.
CONCLUSION: PCOS women have higher serum concentration of TPSA than controls. TPSA positively correlate with T and FAI, which is the best marker for hyperandrogenic states and has better accuracy for tT and total PSA serum levels in diagnostic of PCOS.

Entities:  

Keywords:  Hyperandrogenism; polycystic ovary syndrome; prostate specific antigen; testosterone

Mesh:

Substances:

Year:  2016        PMID: 27426018     DOI: 10.1080/09513590.2016.1200552

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  1 in total

Review 1.  Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis.

Authors:  Zeng-Hong Wu; Yun Tang; Xun Niu; Fei-Fei Pu; Xi-Yue Xiao; Wen Kong
Journal:  J Ovarian Res       Date:  2019-10-15       Impact factor: 4.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.